CDMO Valuation

Healthcare & Life Sciences
Pharma Services Company Valuation: What Are CROs and CDMOs Worth?
ByAuxo Capital AdvisorsJune 19, 2026June 20, 2026
A buyer-focused guide to pharma services company valuation covering normalized EBITDA, CRO and CDMO business-model differences, backlog, sponsor quality, capacity, capex, valuation methods, deal structure, and seller proceeds.
Read More Pharma Services Company Valuation: What Are CROs and CDMOs Worth?
Healthcare & Life Sciences
CDMO M&A: How Buyers Underwrite Contract Development and Manufacturing Organizations
ByAuxo Capital AdvisorsJune 19, 2026June 19, 2026
A practical buyer-underwriting guide to how CDMOs are evaluated in M&A, with emphasis on utilization, campaign economics, quality and compliance risk, backlog durability, customer concentration, capex needs, valuation adjustments, and purchase-price mechanics.
Read More CDMO M&A: How Buyers Underwrite Contract Development and Manufacturing Organizations